Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 283

The DOI matches its Crossref record; 29 of the 29 references it cites were found in a registry or an index.

The Neurotoxicity of Drugs Given Intrathecally (Spinal)

Hodgson, Peter S., Neal, Joseph M., Pollock, Julia E., Liu, Spencer S. · 1999 · Anesthesia & Analgesia

Abstract

A growing understanding of the neuropharmacology of spinal cord processing of nociceptive input has led to intense interest in the use of spinal drugs in anesthesia and pain management. The direct application of receptor-specific therapeutics at the spinal cord can potentially interrupt specific pain pathways and limit systemic side effects, but this practice also carries the inherent risk of injury to the central nervous system. Thus, the neurotoxicity of spinal drugs is a central safety issue. Spinal cord or nerve root toxicity may manifest itself as histologic, physiologic, or behavioral/clinical derangements after exposure to a spinal drug. Neurohistopathology is broadly classified as neural injury, gliosis, or damage to the myelin sheath, and it also describes inflammatory changes and involvement of the arachnoid cell layers. Physiologic neurotoxicity of spinal drugs includes changes in spinal cord blood flow, disruption of the blood-brain barrier, and changes in the electrophysiology of impulse conduction. Behavioral and clinical signs of neurotoxicity include pain, motor and sensory deficits, and bowel and bladder dysfunction. Ideally, a complete roster of histological, physiologic, and behavioral testing would be performed on spinal drugs in several animal species, followed by safety trials in humans before widespread use. In practice, drugs have taken a variety of roads from conception to application, and often without safety data. In this article, we review available neurotoxicity data on drugs that have a clinical application, classified as spinal local anesthetics, spinal analgesics, or spinal adjuvants. Spinal Local Anesthetics The 100-yr history of spinal local anesthetic use in humans has typically involved self-experimentation, followed by widespread application with little or no controlled testing for neurotoxicity. Bier and Hildebrant [1] initially performed spinal anesthesia with cocaine on themselves in 1898, and essentially all of the earliest local anesthetics for spinal anesthesia were introduced in this fashion without toxicity studies. Despite a long history of clinical use, recent interest in neurotoxicity has arisen due to concerns over reports of cauda equina syndrome and transient neurologic symptoms (TNS) from spinal local anesthetics. We review animal data that have been used to assess the neurotoxicity of local anesthetics and summarize data available from human studies. In 1985, Ready et al. [2] evaluated the neurotoxic effects of single injections of local anesthetics in rabbits. They reported that spinal cord histopathology remained normal and that persistent neurologic deficits were not seen with clinically used concentrations of tetracaine, lidocaine, bupivacaine, or chlorprocaine. However, histopathologic changes and neurologic deficits did occur with higher concentrations of tetracaine (1%) and lidocaine (8%). In this model, extensive neurologic impairment was not necessarily accompanied by equally extensive lesions in the spinal cord and nerve roots, thus demonstrating the need for multiple models to fully assess neurotoxicity. Recent studies have used desheathed peripheral nerve models, designed to mimic unprotected nerve roots in the cauda equina, to further assess electrophysiologic neurotoxicity of clinically relevant concentrations of local anesthetics [3-5]. These models demonstrate that clinically used concentrations of 5% lidocaine and 0.5% tetracaine cause irreversible conduction block, whereas 1.5% lidocaine, 0.75% bupivacaine, and 0.06% tetracaine do not. Electrophysiologic toxicity of lidocaine in these models is concentration-dependent (Figure 1) beginning at 40 mM (approximately 1%) with irreversible ablation of the compound action potential at 80 mM (approximately 2%). Kanai et al. [4] subsequently demonstrated that generation of action potentials was more vulnerable than maintenance of resting membrane potential and that irreversible ablation of action and resting membrane potential by lidocaine seems to be both concentration- and time-dependent.Figure 1: The nonreversible effect of 40 mM lidocaine on the compound action potential (CAP) of frog sciatic nerve. Lidocaine was applied to a stable nerve preparation for 15 min, then washed with frog Ringer's solution for 2 h. Tracings represent CAPs in response to stimuli (1-Hz stimulus = heavy line, 40-Hz stimulus = thin line). Lidocaine 40 mM completely ablated the CAP when applied to the nerve. The 1-Hz CAP response began to return after 10-15 min of washing and reached a new level in 45 min, where it was stable for the subsequent 2 h of observation. The recovered 1-Hz CAP is only 65% of the original. Reprinted with the publisher's permission from Holman SJ. Anesthesiology: hyperbaric dye solution distribution. Anesthesiology 1997;86:969.Effects of local anesthetics on spinal cord blood flow seem benign. Spinal administration of bupivacaine, lidocaine, mepivacaine, and tetracaine causes vasodilation and i

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1097/00000539-199904000-00023

Cites

29 of 29 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 29 references

Cited by

See all 283

Metadata

Authors
Hodgson, P. S., Neal, J. M., Pollock, J. E., & Liu, S. S.
Venue
Anesthesia & Analgesia
Published
1999-04
Volume
88
Issue
4
Pages
797-809
ISSN
0003-2999 (ISSN-L)
OpenAlex
W2090823918
Cited by
283
References
29
FWCI
14.27
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: The Neurotoxicity of Drugs Given Intrathecally (Spinal). https://app.cochat.ai/papers/10.1097/00000539-199904000-00023
The paper
Hodgson, P. S., Neal, J. M., Pollock, J. E., & Liu, S. S. (1999). The Neurotoxicity of Drugs Given Intrathecally (Spinal). Anesthesia & Analgesia. https://doi.org/10.1097/00000539-199904000-00023

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.